Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OccuLogix, an ophthalmic device company, doing business as TearLab has appointed Anthony Altig to its board of directors. Mr Altig will also serve as the chairman of the audit committee of the board.
Subscribe to our email newsletter
Mr Altig is the CFO at Pelican Life Sciences, a manufacturer of microbiological and molecularbiological consumables. Mr Altig has also served as a director of Optimer Pharmaceuticals since November 2007.
In addition, Mr Altig currently serves as a director and chair of the audit committee for MultiCell Technologies, a biopharmaceutical company. Mr Altig has received a BS degree from the University of Hawaii.
Eric Donsky, CEO of TearLab, said: “On behalf of the staff and board of TearLab, I would like to welcome Tony to our team. His expertise and understanding of enzyme technology combined with his deep knowledge of the intricacies of the biopharmaceutical industry will help bring significant intellectual capital to TearLab’s board. We look forward to working with Tony and further benefiting from his valuable experience as a public company CFO.”